drugset / Trial / NCT00600977

Liposomal Anthracyclin in the Treatment of Elderly ALL

NCT00600977 ↗

Phase 2 Completed 60 enrolled French Innovative Leukemia Organisation
RandomizedParallel-groupOpen-labelTreatment

Summary

Phase II multicentric study comparing VAD regimen with continuous infusion over 96 hours of doxorubicin, vincristine and dexamethasone to a 90 minutes infusion of equivalent doses of Dox li-PEG, bolus infusion of vincristine and dexamethasone

Timeline

Start
2002-03
Primary completion
—
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxorubicin Other / unclassified 9 mg/m2 Intravenous
Subject Doxorubicin Other / unclassified 40 mg/m2 Intravenous
Subject Doxorubicine pegylated Unknown 40 mg/m2 Intravenous